15.26 USD
↗ 0.24 (1.60%)AT CLOSE (03:59 PM EDT)
Latigo Biotherapeutics, Inc. Common Stock
LTGONASDAQ • USD
15.33
↗ 0.07 (0.46%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
15.33
↗ 0.07 (0.46%)
Market: CLOSED
Latigo Biotherapeutics, Inc. Common Stock (LTGO) is currently trading at $15.26. Technical indicators currently signal "Sell". Notable factors include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Oct 26, 2026.
Open?$15.14
High?$15.49
Low?$14.24
Prev. Close?$15.02
Volume?165.3K
Avg. Volume?N/A
VWAP?$15.07
Bid / Ask
Bid?$14.00 × 400
Ask?$19.25 × 100
Spread?$5.25
Midpoint?$16.63
Valuation & Ratios
Market Cap?995.8M
Shares Out?N/A
Float?50.1M
Float %?79.2%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Employees
N/A
Market Cap
995.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2026-08-07
Address
1300 RANCHO CONEJO BLVD., SUITE 305
THOUSAND OAKS, CA
Phone: 805-716-2927
THOUSAND OAKS, CA
Phone: 805-716-2927
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?1.57%Low
Short Interest?785.9K
Days to Cover?2.5
Free Float50.1M
Avg Daily Volume314.8K
Settlement Date2026-10-15